This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q20 (Congenital malformations of cardiac chambers and connections) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date) |
| B. Synonyms | Atrioventricular connection anomaly, transposition of the great arteries, single ventricle, ventriculoarterial connection anomaly, Ventriculoarterial discordance |
| C. Adult onset | After surgical correction, patients frequently return for care in adulthood due to residual lesions (arrhythmia, heart failure, valve dysfunction), and uncorrected patients are sometimes first diagnosed in adulthood with heart failure or cyanosis. |
| 1. History | Began with 19th-century autopsy descriptions; the era of surgical correction opened after the introduction of cardiopulmonary bypass in the 20th century |
| 2. Causes | Abnormal looping and septation during embryonic heart development; combined genetic and environmental causes |
| 3. Genetics | Associated with variants in NKX2-5, GATA4, TBX1 (22q11.2 deletion), and CFC1 (left–right asymmetry) genes |
| 4. General epidemiology | Overall incidence of congenital heart disease 8–9 per 1,000 live births; Q20 group about 3–5% of the total |
| 5. Pathophysiology | Connection discordance arising from abnormal cardiac looping, atrioventricular septation, and conotruncal rotation |
| 6. Symptoms | Neonatal cyanosis and dyspnea; complete transposition of the great arteries immediately after birth, congenitally corrected transposition may be asymptomatic into adulthood |
| 7. Signs | Cyanosis, murmur, signs of heart failure; congenitally corrected transposition shows abnormal cardiac position and AV block |
| 8. Screening | Prenatal fetal echocardiography, neonatal pulse oximetry, chest X-ray, oxygen saturation monitoring |
| 9. Diagnosis | Echocardiography (transthoracic and transesophageal), cardiac MRI, cardiac catheterization and angiography, genetic testing |
| 10. Treatment | Complete transposition of the great arteries: arterial switch operation (ASO); congenitally corrected transposition: double switch operation or observation; DORV: Rastelli or Biventricular repair |
| 11. Prognosis | 20-year survival after ASO over 90%; watch for coronary artery stenosis, aortic valve regurgitation, and arrhythmia in long-term follow-up |
| 12. Prevention | Preconception folic acid supplementation, prenatal fetal echocardiography, management of diabetes, infection, and drug exposure during pregnancy |
| 13. References | Pathogenesis and Surgical Treatment of Congenitally Corrected Transposition of the Great Arteries … and 9 other papers |
Systematic medical description of congenital malformations of atrial and ventriculoarterial connections dates back to the late 18th century. In 1671, Niels Stensen first described a complex congenital heart malformation at autopsy, and in 1797 Matthew Baillie first clearly described complete transposition of the great arteries (D-TGA). Throughout the 19th century, autopsy pathologists gradually developed the anatomical classification of atrioventricular discordance and ventriculoarterial discordance.
In the first half of the 20th century, Taussig and Blalock's successful systemic-to-pulmonary shunt (BT shunt) for tetralogy of Fallot opened a new era of congenital heart surgery, but complete transposition of the great arteries (D-TGA), a complex malformation requiring atrial-level correction, remained untreatable for a long time. In 1959 Senning first succeeded with intra-atrial blood flow redirection (Senning procedure), and in 1963 Mustard developed a similar atrial switch (Mustard procedure), opening the first era of surgical treatment for D-TGA.
The decisive turning point was the first successful arterial switch operation (ASO) performed by Jatene in Brazil in 1975. By achieving anatomical correction, ASO overcame the long-term complications of earlier physiological correction procedures (right ventricular failure, reversal of systemic–pulmonary flow). With subsequent technical advances, ASO became the standard procedure at major pediatric cardiac surgery centers worldwide in the 1980s–90s. In Korea, since congenital heart surgery using cardiopulmonary bypass began in the 1970s, surgical capability for complex heart malformations has gradually developed, and Asan Medical Center, Severance Hospital, Seoul National University Children's Hospital, and others now report world-class results.
The cause of Q20 group congenital heart malformations is complex developmental abnormality arising during heart formation in embryonic development. The heart begins to form as a simple cardiac tube about 3 weeks after fertilization, then forms a D-loop (dextro-loop), twisting left–right asymmetrically, followed sequentially by atrioventricular separation (AV septation) and conotruncal rotation. If a genetic or environmental disturbance occurs at any stage of this process, abnormal connections between the atria and ventricles, or between the ventricles and great arteries, result.
Genetic causes include single-gene mutations, chromosomal abnormalities, and copy number variants (CNVs). 22q11.2 microdeletion (DiGeorge syndrome) is strongly associated with conotruncal malformations (including transposition of the great arteries) and is one of the most common genetic causes across congenital heart malformations. Known environmental causes include diabetes during pregnancy (especially poorly controlled type 1 diabetes), rubella infection, phenylketonuria, and exposure to retinoic acid, alcohol, and anticonvulsants. Most cases have multifactorial causes, with genetic susceptibility and environmental exposure acting in combination.
Complete transposition of the great arteries (D-TGA) is a state of ventriculoarterial discordance in which normal conotruncal rotation does not occur, so the aorta arises from the right ventricle and the pulmonary artery from the left ventricle. Congenitally corrected transposition of the great arteries (ccTGA) is a form in which atrioventricular discordance and ventriculoarterial discordance occur simultaneously, resulting in functional correction. Double outlet right ventricle (DORV) is a variant in which both the aorta and pulmonary artery arise from the right ventricle, with various anatomical subtypes depending on the location of the ventricular septal defect and the presence of pulmonary stenosis.
The genetics of Q20 group congenital heart malformations are complex and heterogeneous. The most important single-gene factors are variants in cardiac developmental transcription factors. Loss-of-function variants in NKX2-5 (a transcription factor regulating cardiac differentiation) are associated with atrioventricular conduction abnormalities, atrial septal defect, and ventricular structural abnormalities. GATA4 variants can cause great artery connection anomalies together with atrial and ventricular septal defects. CFC1 (crypto-related gene) is involved in left–right asymmetry signaling, and variants in this gene are associated with atrial inversion, situs inversus, and ventriculoarterial connection anomalies.
22q11.2 deletion syndrome (DiGeorge/velocardiofacial syndrome) has TBX1 haploinsufficiency as its key mechanism, and conotruncal malformations (complete transposition of the great arteries, pulmonary atresia, other DORV variants) are its main cardiac phenotypes. This deletion is diagnosed by fluorescence in situ hybridization (FISH) or chromosomal microarray, and screening is recommended across patients with Q20 malformations. 8p23.1 deletion (GATA4 haploinsufficiency) is also associated with atrial and ventricular malformations.
In copy number variant (CNV) analysis, clinically significant CNVs are identified in about 10–15% of patients with Q20 group congenital heart malformations; these are microdeletions/duplications not detected by conventional chromosomal analysis. Whole-exome analysis using next-generation sequencing (NGS) also finds de novo point mutations in about 10–20% of sporadic complex congenital heart malformations, providing important information for genetic counseling and recurrence risk assessment.
Congenital heart disease is the most common congenital malformation, with a worldwide incidence of about 8–9 per 1,000 live births. Of these, atrial and ventriculoarterial connection malformations in the Q20 group account for about 3–5% of all congenital heart disease, occurring in about 2–4 per 10,000 births. In Korea, about 40,000 people are born with congenital heart disease each year, of which complex malformations account for about 15–20%.
Complete transposition of the great arteries (D-TGA) is the most common malformation in the Q20 group, with an incidence of 2.0–3.3 per 10,000 births and about twice as common in boys. Congenitally corrected transposition of the great arteries (ccTGA) is rare at about 0.2–0.5 per 10,000 births, without a large sex difference. Double outlet right ventricle (DORV) occurs at about 0.5–1 per 10,000 births. Some univentricular heart malformations are also included in Q20; these extremely rare anatomical variants are divided into left ventricular type and right ventricular type.
With advances in prenatal diagnostic technology, congenital heart disease is increasingly diagnosed at the fetal stage, and for some severe malformations termination is chosen after fetal diagnosis, so the incidence among live births may be measured lower than the actual incidence. With advances in medical technology, the number of adult patients with congenital heart disease continues to increase, and survival has improved to the point that adult congenital heart disease patients now outnumber pediatric patients in developed countries.
The pathophysiology of Q20 group congenital heart malformations is explained by abnormalities in three key processes of embryonic heart development. The first is abnormal cardiac looping. Normally the cardiac tube forms a loop in the D (rightward) direction, but if abnormalities in left–right asymmetry determinants (the Nodal-Lefty-Pitx2 signaling axis) produce an L-loop (leftward) or incomplete looping, inversion or discordance of the atrioventricular spatial relationship results. This is the basis of complex malformations associated with situs inversus or asplenia syndrome.
The second is abnormal conotruncal rotation. In normal development, the truncus arteriosus rotates about 180° counterclockwise so that the aorta connects to the left ventricle and the pulmonary artery to the right ventricle. If this rotation does not occur, D-TGA develops, in which the aorta connects to the right ventricle. Insufficient rotation or abnormal conal development causes DORV or persistent truncus arteriosus, and the migration and differentiation of neural crest cells play a decisive role in this process.
The third is abnormal atrioventricular septation and valve development. Incomplete fusion of the endocardial cushions causes abnormal formation of the atrioventricular valves and the atrioventricular junction, and the atrioventricular discordance observed in ccTGA is also related to this. The BMP, Notch, and TGF-β signaling pathways are centrally involved in the molecular regulation of this process, and abnormal neural crest cell migration is understood as the common final pathway of conotruncal malformations.
Symptoms of Q20 group malformations span a wide spectrum depending on the type of malformation and associated anomalies, from critical conditions immediately in the neonatal period to cases that remain asymptomatic into adulthood. Complete transposition of the great arteries (D-TGA) is an emergency in which severe cyanosis and dyspnea appear within hours after birth. This is because the two circulations (systemic and pulmonary) are completely separated and connected in parallel, making survival impossible without mixing at the atrial or ventricular level. If an atrial septal defect or patent ductus arteriosus is present, mixing occurs and oxygen saturation rises somewhat.
Congenitally corrected transposition of the great arteries (ccTGA) can be asymptomatic for decades because functionally normal blood flow is maintained, and heart failure symptoms from progressive dysfunction of the systemic right ventricle (the anatomical right ventricle supporting the systemic circulation) sometimes first appear in adulthood. Worsening regurgitation of the associated tricuspid valve (the systemic atrioventricular valve), and dizziness, syncope, and bradycardia due to complete atrioventricular block are also common. Double outlet right ventricle (DORV) is divided into TGA type, Fallot type, VSD type, and intermediate type depending on the location of the associated ventricular septal defect and the presence of pulmonary stenosis, and the presence of cyanosis and the pattern of heart failure differ by subtype.
In D-TGA, generalized cyanosis immediately after birth is the most prominent sign, and the heart is rather quiet on auscultation when there are no associated malformations. Failure of oxygen saturation to improve despite oxygen administration is the most important diagnostic clue to cyanotic congenital heart disease. On chest X-ray, an 'egg-on-side' cardiac silhouette and a narrow superior mediastinum are characteristic.
In ccTGA, a single second heart sound is heard at the 2nd left intercostal space along the left sternal border on cardiac auscultation (the pulmonary valve is located anteriorly), and a tricuspid regurgitation murmur may be heard at the left sternal border. On ECG, AV block and abnormal Q waves (Q waves in the right precordial leads, absent Q waves in the left precordial leads) are characteristic. Situs inversus or rightward deviation of the cardiac axis may also be found on radiological examination. In DORV, cyanosis, murmurs, and signs of heart failure are mixed depending on the associated malformations, and the increased pulmonary blood flow type shows increased respiratory rate and feeding difficulty.
The optimal screening for Q20 group malformations is prenatal fetal echocardiography. When the detailed ultrasound performed at 18–22 weeks of gestation includes the four-chamber view and outflow tract views, 60–80% of major congenital heart malformations can be diagnosed prenatally. The prenatal detection rate of D-TGA has recently improved to 70–90% at specialized centers.
In the neonatal period, pulse oximetry screening is the standardized screening tool for congenital heart disease. Measurements are taken simultaneously on the right wrist and both feet within 24–48 hours after birth; a result below 95% or a difference of 3% or more between the two sites is judged positive, and cardiac evaluation proceeds. With this method, most severe congenital heart malformations, including D-TGA, can be detected early before symptoms appear. Chest X-ray (heart size and shape, pulmonary vascular distribution) and 12-lead ECG are essential components of the initial evaluation.
Echocardiography is the foundation of diagnosis of Q20 group malformations; following segmental analysis, which defines the atrioventricular and ventriculoarterial connections, atrial situs, ventricular looping, and great artery connections are evaluated systematically. Transthoracic echocardiography is used first, and when information is limited, transesophageal echocardiography (TEE) is applied as a supplement. In neonates and infants, the acoustic window is good, so most anatomical information can be obtained noninvasively.
Cardiac MRI (CMR) excels at quantitative assessment of ventricular volume and function, three-dimensional visualization of complex anatomy, and evaluation of perfusion and myocardial fibrosis. It is a key imaging tool that complements echocardiography, particularly for postoperative follow-up and evaluation of adult congenital heart disease. Cardiac catheterization and angiography are performed to assess pulmonary vascular resistance (whether pulmonary hypertension is present) and to plan surgery or interventional procedures. Genetic testing, including chromosomal analysis and FISH, is essential for differentiating associated syndromes such as 22q11.2 deletion and Down syndrome, and whole-exome analysis is performed selectively when identification of a single cause is needed.
Treatment of Q20 group malformations requires highly specific surgical approaches depending on the type of malformation. The standard treatment for D-TGA is the arterial switch operation (ASO), which in principle is performed within 2 weeks of birth (neonatal period). ASO achieves anatomical correction by cross-connecting the aorta and pulmonary artery and transferring the coronary arteries to the neoaorta (the new aorta arising from the anatomical left ventricle). Before surgery or in the period until surgery, mixing of blood flow is secured by balloon atrial septostomy (BAS, Rashkind procedure).
Treatment of ccTGA depends on whether complications are present. When an associated ventricular septal defect and pulmonary stenosis are present, anatomical correction is attempted with the double switch operation (atrial switch + intraventricular baffle or combination with the Rastelli procedure). For DORV, intraventricular rerouting, the Rastelli procedure, the Norwood-Fontan pathway, and others are applied depending on the anatomical subtype. Single ventricle malformations in which definitive biventricular repair is not possible undergo staged single-ventricle palliation (Norwood→Glenn→Fontan) to sequentially separate the systemic and pulmonary circulations.
With advances in modern pediatric cardiac surgery, survival for Q20 group malformations has greatly improved. In D-TGA, 30-day surgical mortality after ASO is less than 1–3% at major centers, and 10-year survival exceeds 90%. However, complications such as neoaortic dilation, coronary artery stenosis or occlusion, recurrent pulmonary stenosis, aortic valve regurgitation, and arrhythmia can occur in long-term follow-up, so lifelong follow-up is essential.
In ccTGA, the systemic right ventricle tends to lose function over the long term after decades, so the risk of heart failure is high in patients aged 60 or older. Anatomical correction with the double switch operation lowers the risk of right ventricular failure, but the surgical risk itself is high, so individualized decisions are needed. Complete AV block occurs at about 2% per year in the natural course of ccTGA, and a permanent pacemaker is often required. Patients with single ventricle malformations who have undergone the Fontan pathway are at risk of long-term complications such as protein-losing enteropathy, Fontan failure, liver fibrosis, and arrhythmia.
Absolute prevention of congenital heart malformations is difficult, but outcomes can be improved through risk factor management and early prenatal diagnosis. There is evidence that preconception folic acid supplementation (0.4–5 mg daily, from at least 1 month before pregnancy through early pregnancy) reduces the risk of neural tube defects and some congenital heart malformations. Blood glucose control during pregnancy significantly lowers the incidence of congenital malformations, including heart malformations, in diabetic mothers.
To prevent viral infections such as rubella, cytomegalovirus (CMV), and coronavirus in early pregnancy (weeks 8–12), checking rubella vaccination status and education on infection prevention are important. Exposure to teratogenic drugs during pregnancy, such as retinoic acid (vitamin A excess), anticonvulsants (valproic acid, phenytoin), and ACE inhibitors, should be avoided. Active use of detailed prenatal fetal echocardiography is key to early detection of congenital heart malformations, delivery planning, and surgical preparation. In particular, when a previous child had congenital heart disease or one of the parents has congenital heart disease, the recurrence risk is 2–5 times higher, so specialized echocardiography is strongly recommended.
Villafañe J, Feinstein JA, Jenkins KJ, et al. Hot topics in tetralogy of Fallot. Journal of the American College of Cardiology. 2013;62(23):2155–2166. DOI: 10.1016/j.jacc.2013.07.100. PMID: 24076282.
Khairy P, Ionescu-Ittu R, Mackie AS, et al. Changing mortality in congenital heart disease. Journal of the American College of Cardiology. 2010;56(14):1149–1157. DOI: 10.1016/j.jacc.2010.03.085. PMID: 20863959.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. Journal of the American College of Cardiology. 2008;52(23):e1–e121. DOI: 10.1016/j.jacc.2008.10.001. PMID: 19038677.
Jatene AD, Fontes VF, Paulista PP, et al. Anatomic correction of transposition of the great vessels. Journal of Thoracic and Cardiovascular Surgery. 1976;72(3):364–370. DOI: 10.1016/S0022-5223(19)40594-0. PMID: 960814.
Pundi KN, Johnson JN, Dearani JA, et al. 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. Journal of the American College of Cardiology. 2015;66(15):1700–1710. DOI: 10.1016/j.jacc.2015.07.065. PMID: 26449143.
Moons P, Bovijn L, Budts W, et al. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122(22):2264–2272. DOI: 10.1161/CIRCULATIONAHA.110.946343. PMID: 21060073.
Van Praagh R. The segmental approach to diagnosis in congenital heart disease. Birth Defects Original Article Series. 1972;8(5):4–23. PMID: 4656133.
Massin MM. Contemporary outcomes of complete atrioventricular septal defect repair in children. World Journal for Pediatric and Congenital Heart Surgery. 2014;5(1):90–95. DOI: 10.1177/2150135113509604. PMID: 24285465.
Moons P, Sluysmans T, De Wolf D, et al. Congenital heart disease in 111,225 births in Belgium: birth prevalence, treatment and outcome in the 21st century. Acta Paediatrica. 2009;98(3):472–477. DOI: 10.1111/j.1651-2227.2008.01152.x. PMID: 19120042.
Khairy P, Clair M, Fernandes SM, et al. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013;127(3):331–339. DOI: 10.1161/CIRCULATIONAHA.112.114355. PMID: 23247302.